Cervical Intraepithelial Neoplasia (CIN) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Cervical Intraepithelial Neoplasia (CIN) – Drugs In Development, 2024 report and make more profitable business decisions.
Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, is characterized by the abnormal appearance of cells on the surface of the cervix. Cervical dysplasia usually occurs in women ages 25 to 35. Most cases of cervical dysplasia are caused by human papillomavirus (HPV). Factors contributing to cervical dysplasia include using immunosuppressants and smoking. Signs and symptoms include genital warts, abnormal bleeding, spotting after intercourse, vaginal discharge, and low back pain.
The Cervical Intraepithelial Neoplasia (CIN) drugs in development market research report provide comprehensive information on the therapeutics under development for Cervical Intraepithelial Neoplasia (CIN), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Cervical Intraepithelial Neoplasia (CIN) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Cervical Intraepithelial Neoplasia (CIN) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 39 molecules, with 31 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Cervical Intraepithelial Neoplasia (CIN) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Cervical Intraepithelial Neoplasia (CIN) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Cervical Intraepithelial Neoplasia (CIN) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Antiva Biosciences IncApolloBio Corp
Barinthus Biotherapeutics Plc
Beijing Health Guard Biotechnology Inc
Bioleaders Corp
Blue Sky Immunotherapies GmbH
CEL-SCI Corp
Chengdu Institute of Biological Products Co Ltd
Dare Bioscience Inc
Douglas Pharmaceuticals Ltd
Frantz Viral Therapeutics LLC
Genexine Inc
Hefei Ruichengsheng Biotechnology Co Ltd
Huazhong University of Science & Technology
Inovio Pharmaceuticals Inc
Jiangsu Yahong Meditech Co Ltd
KinoPharma Inc
Merck & Co Inc
Newish Technology Beijing Co Ltd
Nihon University
Novan Inc
Nutcracker Therapeutics Inc
Nykode Therapeutics ASA
Papivax LLC
PDS Biotechnology Corp
Shanghai Bovax Biotechnology Co Ltd
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Shenzhen People's Hospital
Sun Yat-sen University
Transgene SA
University of Arkansas
University of Oklahoma
Vaxart Inc
ViciniVax BV
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Cervical Intraepithelial Neoplasia (CIN) reports